Idasanutlin 10 mg | 99.55%
TargetMol
Idasanutlin (RG-7388) is an effective and specific p53-MDM2 inhibitor (IC50: 6 nM).
More Information Supplier PageIdasanutlin
Search Results
Masitinib 200 mg | 99.91%
TargetMol
Masitinib is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in animals, specifically dogs. Since its introduction in November 2008 it has been distributed under the commercial name Masivet. It has been available in Europe since the second part of 2009. In the USA it is distributed under the name Kinavet and […]
More Information Supplier PageMasitinib
Masitinib 100 mg | 99.91%
TargetMol
Masitinib is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in animals, specifically dogs. Since its introduction in November 2008 it has been distributed under the commercial name Masivet. It has been available in Europe since the second part of 2009. In the USA it is distributed under the name Kinavet and […]
More Information Supplier PageMasitinib
VER-155008 10 mg | 98.88%
TargetMol
VER-155008 is a potent Hsp70 family inhibitor with IC50 of 0.5 μM, 2.6 μM, and 2.6 μM in cell-free assays for HSP70, HSC70, and GRP78, respectively, >100-fold selectivity over HSP90.
More Information Supplier PageVER-155008
Idasanutlin 5 mg | 99.55%
TargetMol
Idasanutlin (RG-7388) is an effective and specific p53-MDM2 inhibitor (IC50: 6 nM).
More Information Supplier PageIdasanutlin
Idasanutlin 50 mg | 99.55%
TargetMol
Idasanutlin (RG-7388) is an effective and specific p53-MDM2 inhibitor (IC50: 6 nM).
More Information Supplier PageIdasanutlin
Idasanutlin 2 mg | 99.55%
TargetMol
Idasanutlin (RG-7388) is an effective and specific p53-MDM2 inhibitor (IC50: 6 nM).
More Information Supplier PageIdasanutlin
SU5214 5 mg | Purity Not Available
TargetMol
SU5214
Dihydroethidium 25 mg | 99.52%
TargetMol
Dihydroethidium
SU5214 25 mg | Purity Not Available
TargetMol
SU5214